James Davidson joined the company in 1997; shortly after gaining his PhD from the Department of Chemistry at the University of Cambridge.
During his time at Vernalis, James has worked on numerous protein target classes and therapeutic indications, and is a co-inventor on over 20 patents. Most recently he has led the chemistry efforts on projects targeting Bcl-2 family proteins for cancer.
Alongside project direction, James heads up our scientific computing and software development team, whose goal is to provide tools that help our scientists make the best decisions possible, as efficiently as possible.
